β受体阻滞剂-话题@MedSci

#β受体阻滞剂#

106篇内容 | 3810人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1274977, encodeId=dc1612e497729, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, objectType=article, longId=154613, objectId=fd541546136d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd541546136d, replyNumber=0, likeNumber=80, createdTime=2018-11-30, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd541546136d, moduleTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd541546136d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274976, encodeId=f24812e497624, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, objectType=article, longId=152882, objectId=97e515288294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e515288294, replyNumber=0, likeNumber=62, createdTime=2018-11-08, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e515288294, moduleTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e515288294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274975, encodeId=73f712e497525, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, objectType=article, longId=151198, objectId=77581511982e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77581511982e, replyNumber=0, likeNumber=48, createdTime=2018-10-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77581511982e, moduleTitle=Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77581511982e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274974, encodeId=91d912e49744f, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, objectType=article, longId=151179, objectId=10aa1511e908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10aa1511e908, replyNumber=0, likeNumber=72, createdTime=2018-10-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10aa1511e908, moduleTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10aa1511e908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274973, encodeId=aa4012e497364, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, objectType=article, longId=150404, objectId=af2015040478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af2015040478, replyNumber=0, likeNumber=69, createdTime=2018-10-07, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af2015040478, moduleTitle=Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af2015040478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274972, encodeId=511012e4972ac, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, objectType=article, longId=150169, objectId=8923150169bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8923150169bb, replyNumber=0, likeNumber=73, createdTime=2018-10-02, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8923150169bb, moduleTitle=JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8923150169bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274971, encodeId=aaba12e4971e6, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, objectType=article, longId=149357, objectId=2f0e14935ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0e14935ebb, replyNumber=0, likeNumber=86, createdTime=2018-09-24, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0e14935ebb, moduleTitle=JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0e14935ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274970, encodeId=0c7012e497014, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, objectType=article, longId=141676, objectId=ab751416e6bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab751416e6bd, replyNumber=0, likeNumber=85, createdTime=2018-06-28, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab751416e6bd, moduleTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab751416e6bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274969, encodeId=7fa112e49695a, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险, objectType=article, longId=135004, objectId=878013500472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878013500472, replyNumber=0, likeNumber=83, createdTime=2018-04-13, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878013500472, moduleTitle=Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878013500472)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274968, encodeId=674412e4968ec, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=糖尿病患者：我能不能用β受体阻滞剂？, objectType=article, longId=133855, objectId=52b31338551a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52b31338551a, replyNumber=0, likeNumber=57, createdTime=2018-03-31, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52b31338551a, moduleTitle=糖尿病患者：我能不能用β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52b31338551a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274967, encodeId=14c012e4967df, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Eur Heart J Acute Cardiovasc Care：长期应用β受体阻滞剂是否会增加STEMI患者心源性休克的发生风险？, objectType=article, longId=132917, objectId=e0bb13291e44, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0bb13291e44, replyNumber=0, likeNumber=73, createdTime=2018-03-21, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0bb13291e44, moduleTitle=Eur Heart J Acute Cardiovasc Care：长期应用β受体阻滞剂是否会增加STEMI患者心源性休克的发生风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0bb13291e44)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274966, encodeId=4b8312e49665b, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=ACC 2018：CECCY研究：β受体阻滞剂对化疗心肌毒性是否有预防价值仍有待进一步探讨, objectType=article, longId=132572, objectId=d3d61325e2bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3d61325e2bf, replyNumber=0, likeNumber=68, createdTime=2018-03-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3d61325e2bf, moduleTitle=ACC 2018：CECCY研究：β受体阻滞剂对化疗心肌毒性是否有预防价值仍有待进一步探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3d61325e2bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274965, encodeId=e9ff12e4965b8, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Eur Heart J：β受体阻滞剂能改善心衰伴LVEF降低患者的预后, objectType=article, longId=125897, objectId=d55112589e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d55112589e5c, replyNumber=0, likeNumber=90, createdTime=2018-01-09, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55112589e5c, moduleTitle=Eur Heart J：β受体阻滞剂能改善心衰伴LVEF降低患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d55112589e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274964, encodeId=9f6812e49646e, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAHA：β受体阻滞剂不会增加轻、中度AS患者的心血管风险, objectType=article, longId=125065, objectId=e2f5125065f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2f5125065f6, replyNumber=0, likeNumber=61, createdTime=2017-12-31, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2f5125065f6, moduleTitle=JAHA：β受体阻滞剂不会增加轻、中度AS患者的心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2f5125065f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274963, encodeId=e97012e49633f, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=急性心力衰竭时，β受体阻滞剂——用还是不用？这是个问题！, objectType=article, longId=123333, objectId=ba9f1233334d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba9f1233334d, replyNumber=0, likeNumber=91, createdTime=2017-12-15, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba9f1233334d, moduleTitle=急性心力衰竭时，β受体阻滞剂——用还是不用？这是个问题！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba9f1233334d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274962, encodeId=650612e4962d8, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Sci Tran Med：研究发现β受体阻滞剂对肺癌治疗具有极大的帮助！, objectType=article, longId=119435, objectId=6cd611943557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cd611943557, replyNumber=0, likeNumber=90, createdTime=2017-11-11, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cd611943557, moduleTitle=Sci Tran Med：研究发现β受体阻滞剂对肺癌治疗具有极大的帮助！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cd611943557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274961, encodeId=b1fd12e496151, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAHA：经皮冠状动脉介入术后急性心肌梗死患者血管扩张型β受体阻滞剂的效果分析！, objectType=article, longId=117755, objectId=9c5611e75599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c5611e75599, replyNumber=0, likeNumber=88, createdTime=2017-10-28, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c5611e75599, moduleTitle=JAHA：经皮冠状动脉介入术后急性心肌梗死患者血管扩张型β受体阻滞剂的效果分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c5611e75599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274960, encodeId=3d7712e4960ea, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？, objectType=article, longId=116836, objectId=5f23116836cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f23116836cc, replyNumber=0, likeNumber=30, createdTime=2017-10-21, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f23116836cc, moduleTitle=Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f23116836cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274959, encodeId=bb9112e49590b, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JACC：β受体阻滞剂对急性心梗后患者的收益有限, objectType=article, longId=113343, objectId=dfca11334355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfca11334355, replyNumber=0, likeNumber=76, createdTime=2017-09-21, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfca11334355, moduleTitle=JACC：β受体阻滞剂对急性心梗后患者的收益有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfca11334355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274958, encodeId=cef112e495820, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JCI Insight：研究证实β受体阻滞剂用于这类肺部疾病的神奇功效！, objectType=article, longId=111700, objectId=83ad111e00e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ad111e00e5, replyNumber=0, likeNumber=59, createdTime=2017-09-03, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ad111e00e5, moduleTitle=JCI Insight：研究证实β受体阻滞剂用于这类肺部疾病的神奇功效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ad111e00e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

β受体阻滞剂

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？

2018-11-30

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系

2018-11-08

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Am J Cardiol：心衰患者用>25 mg/d的β受体阻滞剂降低死亡率

2018-10-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险

2018-10-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Brit J Surg：β受体阻滞剂治疗对急诊结肠癌术后早期死亡率的影响

2018-10-07

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAHA：急性心梗伴肝硬化患者的β受体阻滞剂该如何选择？

2018-10-02

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAHA：肝硬化合并急性心肌梗死患者β受体阻滞剂的选择

2018-09-24

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！

2018-06-28

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Mayo Clin Proc：β受体阻滞剂增加冠心病糖尿病患者死亡风险

2018-04-13

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

糖尿病患者：我能不能用β受体阻滞剂？

2018-03-31

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Eur Heart J Acute Cardiovasc Care：长期应用β受体阻滞剂是否会增加STEMI患者心源性休克的发生风险？

2018-03-21

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

ACC 2018：CECCY研究：β受体阻滞剂对化疗心肌毒性是否有预防价值仍有待进一步探讨

2018-03-17

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Eur Heart J：β受体阻滞剂能改善心衰伴LVEF降低患者的预后

2018-01-09

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAHA：β受体阻滞剂不会增加轻、中度AS患者的心血管风险

2017-12-31

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

急性心力衰竭时，β受体阻滞剂——用还是不用？这是个问题！

2017-12-15

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Sci Tran Med：研究发现β受体阻滞剂对肺癌治疗具有极大的帮助！

2017-11-11

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAHA：经皮冠状动脉介入术后急性心肌梗死患者血管扩张型β受体阻滞剂的效果分析！

2017-10-28

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？

2017-10-21

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JACC：β受体阻滞剂对急性心梗后患者的收益有限

2017-09-21

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JCI Insight：研究证实β受体阻滞剂用于这类肺部疾病的神奇功效！

2017-09-03

科室
- - 订阅+
  - 更多科室
工具
服务